Mid-Day Commentary & Reports for : (NASDAQ: PPHM), (NYSE: STP)
Posted on January 08, 2013 at 13:35 PM EST
New York, NY -- (SBWIRE) -- 01/08/2013 -- Peregrine Pharmaceuticals (NASDAQ: PPHM), a biopharmaceutical company engaged in the research and development of monoclonal antibodies for the treatment and diagnosis of cancer and viral infections, is down in trading today, following the huge rally in the previous trading session.